Consultant- Cytogenetics
Part-time
Description
<span><span><span><span><span><span><span><span><span><span><span><span><span><span><span><span><span><span><span><span><span><span><span><span><span><span><span><span><span><span><span><span><span><h2><span><span><span><b>Job Title</b></span></span></span></h2></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span>Consultant- Cytogenetics<span><span><span><span><span><span><span><span><span><span><span><span><span><span><span><span><span><span><span><span><span><span><span><span><span><span><span><span><span><span><span><span><span><h2><br><span><span><span><b>Location(s)</b></span></span></span></h2></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span></span>Chennai - Remote (Home Based)<p></p><p><b><span>About Us</span></b></p><p></p><p><span>Revvity is a developer and provider of end-to-end solutions designed to help scientists, researchers, and clinicians solve the world’s greatest health challenges. We pair the enthusiasm of an industry disruptor with the experience of a longtime leader. Our team of 11,000+ colleagues from around the globe are vital to our success and the reason we’re able to push boundaries in pursuit of better human health.</span><span> </span></p><p></p><p>Find your future at Revvity </p><p></p><ul><li>Checking karyotype images and advising the results</li><li>Checking karyotype images and confirm team’s results and nomenclature</li><li>Ensure ICSN nomenclature is followed appropriately for all cases reported out</li><li><span>Work timing would be based on either </span><ul><li><span>Minimum cases per day as per mutually agreed terms </span></li></ul></li><li><ul><li><span>Minimum time of 2 to 3 hrs per day as mutually agreed</span></li></ul></li><li>Training the <span>team to be competent in identification and representing the karypotype abnormalities as per ISCN 2020</span></li></ul>